Suzanne Meiring

Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study

Annieke C.G. van Baar, Suzanne Meiring, Paul Smeele et al. · Gastrointestinal Endoscopy · 2020 · 44 citations · Full text

Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes

Suzanne Meiring, Emma C. E. Meessen, Annieke C.G. van Baar et al. · American Journal of Physiology-Endocrinology and Metabolism · 2021 · 19 citations · Full text

Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot study

Celine B.E. Busch, Suzanne Meiring, Annieke C.G. van Baar et al. · Gastrointestinal Endoscopy · 2024 · 16 citations · Full text

A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study

Suzanne Meiring, Annieke C.G. van Baar, Nikolaj Sørensen et al. · Frontiers in Clinical Diabetes and Healthcare · 2022 · 13 citations · Full text

Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome

Nienke van Olst, Suzanne Meiring, Maurits de Brauw et al. · Techniques and Innovations in Gastrointestinal Endoscopy · 2020 · 12 citations · Full text